-
Something wrong with this record ?
Recommendations from the European guidelines for the diagnosis and therapy of pancreatic exocrine insufficiency
M. Vujasinovic, D. Iglesia, JE. Dominguez-Muñoz, JM. Löhr, European PEI Multidisciplinary Group
Language English Country Switzerland
Document type Journal Article, Practice Guideline
- MeSH
- Exocrine Pancreatic Insufficiency * diagnosis therapy etiology MeSH
- Humans MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Practice Guideline MeSH
- Geographicals
- Europe MeSH
BACKGROUND: Pancreatic exocrine insufficiency (PEI) is defined as a reduction in pancreatic exocrine secretion below a level that allows normal digestion of nutrients. Pancreatic disease and pancreatic surgery are the main causes of PEI, but other conditions can affect the digestive function of the pancreas. METHODS: In collaboration with European Digestive Surgery (EDS), European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), European Society for Clinical Nutrition and Metabolism (ESPEN), European Society of Digestive Oncology (ESDO), and European Society of Primary Care Gastroenterology (ESPCG) the working group developed European guidelines for the diagnosis and therapy of PEI. United European Gastroenterology (UEG) provided both endorsement and financial support for the development of the guidelines. RESULTS: Recommendations covered topics related to the clinical management of PEI: concept, pathogenesis, clinical relevance, general diagnostic approach, general therapeutic approach, PEI secondary to chronic pancreatitis, PEI after acute pancreatitis, PEI associated with pancreatic cancer, PEI secondary to cystic fibrosis, PEI after pancreatic surgery, PEI after esophageal, gastric, and bariatric surgery, PEI in patients with type 1 and type 2 diabetes, and PEI in other conditions. CONCLUSIONS: The European guidelines for the diagnosis and therapy of PEI provide evidence-based recommendations concerning key aspects of the etiology, diagnosis, therapy, and follow-up, based on current available evidence. These recommendations should serve as a reference standard for existing management of PEI and as a guide for future clinical research. This article summarizes the recommendations and statements.
Department of Gastroenterology University Hospital Puerta de Hierro Madrid Spain
Department of Medicine Huddinge Karolinska Institute Stockholm Sweden
Department of Upper Abdominal Diseases Karolinska University Hospital Stockholm Sweden
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015913
- 003
- CZ-PrNML
- 005
- 20250731091343.0
- 007
- ta
- 008
- 250708s2025 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.pan.2025.02.015 $2 doi
- 035 __
- $a (PubMed)40097316
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Vujasinovic, Miroslav $u Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden. Electronic address: miroslav.vujasinovic@regionstockholm.se
- 245 10
- $a Recommendations from the European guidelines for the diagnosis and therapy of pancreatic exocrine insufficiency / $c M. Vujasinovic, D. Iglesia, JE. Dominguez-Muñoz, JM. Löhr, European PEI Multidisciplinary Group
- 520 9_
- $a BACKGROUND: Pancreatic exocrine insufficiency (PEI) is defined as a reduction in pancreatic exocrine secretion below a level that allows normal digestion of nutrients. Pancreatic disease and pancreatic surgery are the main causes of PEI, but other conditions can affect the digestive function of the pancreas. METHODS: In collaboration with European Digestive Surgery (EDS), European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), European Society for Clinical Nutrition and Metabolism (ESPEN), European Society of Digestive Oncology (ESDO), and European Society of Primary Care Gastroenterology (ESPCG) the working group developed European guidelines for the diagnosis and therapy of PEI. United European Gastroenterology (UEG) provided both endorsement and financial support for the development of the guidelines. RESULTS: Recommendations covered topics related to the clinical management of PEI: concept, pathogenesis, clinical relevance, general diagnostic approach, general therapeutic approach, PEI secondary to chronic pancreatitis, PEI after acute pancreatitis, PEI associated with pancreatic cancer, PEI secondary to cystic fibrosis, PEI after pancreatic surgery, PEI after esophageal, gastric, and bariatric surgery, PEI in patients with type 1 and type 2 diabetes, and PEI in other conditions. CONCLUSIONS: The European guidelines for the diagnosis and therapy of PEI provide evidence-based recommendations concerning key aspects of the etiology, diagnosis, therapy, and follow-up, based on current available evidence. These recommendations should serve as a reference standard for existing management of PEI and as a guide for future clinical research. This article summarizes the recommendations and statements.
- 650 12
- $a exokrinní pankreatická insuficience $x diagnóza $x terapie $x etiologie $7 D010188
- 650 _2
- $a lidé $7 D006801
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 700 1_
- $a Iglesia, Daniel de la $u Department of Gastroenterology, University Hospital Puerta de Hierro, Madrid, Spain
- 700 1_
- $a Dominguez-Muñoz, J Enrique $u Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
- 700 1_
- $a Löhr, J Matthias $u Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Sciences, Karolinska Institute and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden
- 710 2_
- $a European PEI Multidisciplinary Group
- 773 0_
- $w MED00008752 $t Pancreatology $x 1424-3911 $g Roč. 25, č. 3 (2025), s. 293-300
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40097316 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091337 $b ABA008
- 999 __
- $a ok $b bmc $g 2366627 $s 1253038
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 25 $c 3 $d 293-300 $e 20250228 $i 1424-3911 $m Pancreatology $n Pancreatology $x MED00008752
- LZP __
- $a Pubmed-20250708